Cell Culture Market Definition
Industry Perspective:
The global cell culture market was worth USD 22.22 billion in 2022 and is estimated to grow to USD 55.30 billion by 2030, with a compound annual growth rate (CAGR) of approximately 12.07% over the forecast period. The report analyzes the cell culture market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the Cell Culture market.
Cell Culture Market: Overview
Cell culture is a global industry that offers goods and services for growing cells under regulated conditions. Cell culture is a vital biological technique that has a wide range of uses, including biopharmaceutical production, medication discovery, and research and development. In addition, numerous commercial items, including vaccines, diagnostic tools, and cell-based therapeutics, are also produced using it. Further, in the upcoming years, the market for cell culture is anticipated to expand quickly due to the rising need for cell-based therapies and other cutting-edge medical procedures. The expanding usage of cell culture in fundamental research and drug discovery is another factor driving the market.
COVID-19 Impact:
The COVID-19 epidemic has significantly impacted the market for cell culture. On the one hand, as researchers and pharmaceutical companies raced to discover vaccines and therapies for COVID-19, the pandemic has resulted in an increased demand for cell culture goods and services. On the other hand, the pandemic has also affected the cell culture sector in other ways by upsetting supply networks and creating economic uncertainty.
nForming Cell Culture Market Smart Book
The nForming Cell Culture Market Smart Books offer a comprehensive compilation of data pertaining to historical revenue, user volume, patient data, prices, and other relevant information for each segment. This includes, products & services, type of indication, age group and detailed analysis of service providers with coverage at both regional and country levels. The data spans the past three years and provides projections up until 2030. The smart book also provides extensive information on the leading suppliers and their corresponding market shares in the Cell Culture Market. The Cell Culture Market comprises a range of qualitative factors, including significant growth drivers, opportunities, and challenges.
Cell Culture Market Recent Developments
The cell culture industry is seeing a variety of developments. Among the major developments areas are;
Recent Developments
- June 2023: Evonik introduced the cQrex cell culture component portfolio to improve efficiency and productivity in bioprocesses for manufacturing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells.
- February 2022: The Cell Performance CompanyTM, Nucleus Biologics, is pleased to announce the release of KrakatoaTM, a cutting-edge, first-to-market media maker that will enable researchers to produce cell culture medium at the point of use.
Read more opportunities of cell culture market in the Smart Book.
Cell Culture Market Drivers
A rise in the demand for cell culture-related goods and services to promote Cell Culture to drive market growth
The cell culture market is expanding as a result of the rising demand for products and services related to cell culture. The process of cell culture is used to develop cells outside of an organism in a controlled environment. There are many different uses for it, such as gene therapies, vaccines, monoclonal antibodies, and other biopharmaceutical products that are all produced using cell culture. Cell culture is also used to investigate the safety and effectiveness of novel medications and treatments. The impact of toxins and other substances on cells is also studied via cell culture.
In addition, for regenerative medicine treatments like stem cell therapy, cell culture is also utilized to generate the cells that will be employed in those treatments.
Cell Culture Market: Restraints
High costs and complexity hinder market growth.
A major obstacle to the expansion of the cell culture sector is the high cost and complexity of the methods involved. This is especially true for cutting-edge technologies like 3D cell culture, which call for specialized tools and knowledge. Several variables, such as the type of cells being cultivated, the size of the operation, and the particular needs of the application, might affect the cost of cell culture.
Read all major drivers and trends of cell culture market in the Smart Book.
Cell Culture Market Regional Landscape
North America dominated the Cell Culture market in 2022
The market’s expansion is attributable to the region’s well-established pharmaceutical and biotech sectors and the widely adopted, cutting-edge technologies in the United States. Additionally, there is a sizable market for cell culture technology because numerous institutions have invested a lot of time and money in cell therapy research. The increasing frequency of chronic and infectious diseases in this area has increased the need for cell culturing methods in research and clinical applications.
Read more competitive developments in the Cell Culture Market Smart Book.
Molecular Diagnostics Market Key Companies
- Thermo Fisher Scientific
- Danaher Corporation
- Sartorius AG
- Merck KGaA
- Corning Incorporated
- Becton
- Dickinson and Company
- Lonza Group
- Eppendorf SE
- Bio-Techne Corporation
- PromoCell GmbH
- Agilent Technologies Inc.
Cell Culture Market Segmentation:
The global cell culture market has been segmented into products and applications.
Based on products, consumables, and equipment are segments of the global cell culture market. The consumables segment dominated the market in 2022 because of consistent demand and consumable purchases. An additional element driving the segment’s expansion is a surge in R&D spending by biotechnology and biopharmaceutical companies to create advanced biologics, including monoclonal antibodies and vaccines. During the projection period, it is anticipated that demand for consumables will remain high. Reagents, media, and sera are further divisions of the consumables market.
Based on application, the market is classified into biopharmaceuticals, drug development, gene therapy, tissue culture and engineering, vaccine production, and others. In 2022, the biopharmaceuticals category dominated the global market. Because of the usage of mammalian cell lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the increasing demand for alternative therapies, biopharmaceutical uses of cell culture techniques are expected to grow. Furthermore, recent advancements in grafting processes and new options in personalized therapy have expanded the biopharmaceutical domain’s potential.
Segmentation:
Cell Culture Market, By Product |
|
Cell Culture Market, by Application |
|
Cell Culture Market, by End-User |
|
Cell Culture Market, By Geography |
|
Frequently Asked Questions (FAQs):
- Which key factors will influence cell culture market growth over 2023-2030?
The main reasons anticipated to propel the cell culture market during the forecast period are the development of 3D cell culture techniques and the expanding use of these techniques for tissue engineering, drug discovery, and biopharmaceutical production.
- What will be the value of the cell culture market during 2022-2030?
According to the report, the global cell culture market size was worth USD 22.22 billion in 2022 and is estimated to grow to USD 55.30 billion by 2030, with a compound annual growth rate (CAGR) of approximately 12.07% over the forecast period.
- Which region will contribute notably towards the cell culture market value?
North America is anticipated to continue leading the cell culture market throughout the projected period.
- Which are the major players leveraging the cell culture market growth?
Some of the main competitors dominating the global cell culture market include – Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA, Corning Incorporated, Becton, Dickinson and Company, Lonza Group, Eppendorf SE, Bio-Techne Corporation, PromoCell GmbH, and Agilent Technologies Inc.
Pingback: Cell Culture Market - The Future is Cellular: Unlocking the Potential of Cell Culture Technology - Journal of Cyber Policy